Current Concepts on Immunopathology of COVID-19 and Emerging Therapies

AuthorLeila Azimien
AuthorAbdollah Karimien
AuthorMasoud Alebouyehen
AuthorArmin Shirvanien
AuthorSaeid Mahamen
AuthorSedigheh Rafiei Tabatabaeien
AuthorShahnaz Arminen
AuthorFatemeh Fallahen
AuthorMaryam Rajabnejaden
AuthorSeyed Alireza Fahimzaden
AuthorFariba Shirvanien
AuthorRoxana Mansour Ghanaieen
OrcidLeila Azimi [0000-0002-7216-2530]en
OrcidAbdollah Karimi [0000-0002-4225-0097]en
OrcidMasoud Alebouyeh [0000-0001-7474-2515]en
OrcidArmin Shirvani [0000-0001-9048-8289]en
OrcidSedigheh Rafiei Tabatabaei [0000-0003-1723-9424]en
OrcidShahnaz Armin [0000-0002-4993-482X]en
OrcidFatemeh Fallah [0000-0003-4455-1536]en
OrcidMaryam Rajabnejad [0000-0003-3228-2922]en
OrcidSeyed Alireza Fahimzad [0000-0001-6054-0656]en
OrcidFariba Shirvani [0000-0002-4893-6452]en
OrcidRoxana Mansour Ghanaie [0000-0001-7475-0240]en
Issued Date2020-07-01en
AbstractContext: This scoping review tries to synthesize early findings on the immunopathogenicity of SARS-CoV-2 to assess the emerging therapies and vaccines by evaluating their impact based on the mechanism of pathogenicity. Methods: The three databases of PubMed, Scopus, and Google Scholar were searched from January 1, 2020, to March 15, 2020. To extract the results from the studies, the content, thematic analysis method was used. In this method, the topics studied were coded in the articles, and then major topics related to the articles were determined. After identifying major issues, the contents of the articles were reviewed. Results: A total of 2,250 articles were retrieved after deleting duplications, and after reviewing the thematic relevance, 45 of them were selected for the final analysis. Topics studied in the articles were classified into four main areas, including “virus entry inhibition and immune response”, “vaccine and treatment targets”, “genome structure similarity to other coronaviruses,” and “pathogensis”. Conclusions: Results of this review showed that we have a long way to develop an effective and safe vaccine due to the structural and behavioral complexities of this virus. In the meantime, the scientific community should use results of megatrials, but until their accomplishing them, we have to use results of systematic reviews of randomized controlled trials.en
DOIhttps://doi.org/10.5812/pedinfect.104266en
URIhttps://brieflands.com/journals/apid/articles/104266en
KeywordSARS-CoV-2en
KeywordCOVID-19en
KeywordPathogenesisen
KeywordVaccineen
KeywordTreatmenten
PublisherBrieflandsen
TitleCurrent Concepts on Immunopathology of COVID-19 and Emerging Therapiesen
TypeReview Articleen

Files